Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569867 · ClinicalTrials.gov registry record
Genetic Influences on Statin Blood Concentrations in African Americans
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 501
- Enrollment target
NCT01569867: Completed study, sponsored by Ohio State University.
NCT01569867 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 501 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01569867 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 501 participants
- Enrollment target
Study Summary
This study intends to determine the effects of genetic polymorphisms on statin response and daily systemic exposure (24-hour area under the time-concentration curve) of statins in African-American patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 2012-03 |
| Est. Completion | 2022-04-20 |
What the finished NCT01569867 record still lists
NCT01569867 is an observational study that tracks outcomes without assigning an intervention. The registered 501 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01569867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01569867 about?
NCT01569867 is a clinical study titled "Genetic Influences on Statin Blood Concentrations in African Americans". This study intends to determine the effects of genetic polymorphisms on statin response and daily systemic exposure (24-hour area under the time-concentration curve) of statins in African-American patients.
What is the current status of trial NCT01569867?
This trial is currently completed. The enrollment target is 501 participants. The study started on 2012-03. Estimated completion is 2022-04-20.
Who is sponsoring clinical trial NCT01569867?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06934525 · 501 participants · NA
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia